Bhalla Narinder Pal
SEC CIK 2109299 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Chief Medical Off | 82.2K | — | $98.6K | 3 | 2026-02-13 | 2026-07-01 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 18:48 | 2026-06-29 | LXEO | Lexeo Therapeutics, Inc. | Bhalla Narinder Pal | Chief Medical Off | A - Grant | $0.00 | +55.0K | 104.5K | +111% | $0 | |
| 2026-07-01 18:48 | 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | Bhalla Narinder Pal | Chief Medical Off | S - Sale | $4.42 | -22.3K | 82.2K | -21% | -$98.6K | |
| D | 2026-02-17 | 2026-02-13 | LXEO | Lexeo Therapeutics, Inc. | Bhalla Narinder Pal | Chief Medical Off | A - Grant | $0.00 | +49.5K | 49.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations